Related references
Note: Only part of the references are listed.A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (Twinrab™) Against Human Rabies Immunoglobulin (HRIG)
Kevinkumar Kansagra et al.
CLINICAL INFECTIOUS DISEASES (2021)
Towards rabies elimination in the Asia-Pacific region: From theory to practice
Charles E. Rupprecht et al.
BIOLOGICALS (2020)
Towards the elimination of dog-mediated rabies: development and application of an evidence-based management tool
Kristyna Rysava et al.
BMC INFECTIOUS DISEASES (2020)
Preparation and qualification of internal rabies reference standards for use in the rabies rapid fluorescent focus inhibition test
Tatyana M. Timiryasova et al.
SCIENTIFIC REPORTS (2020)
Fighting Dog-Mediated Rabies in Namibia-Implementation of a Rabies Elimination Program in the Northern Communal Areas
Rauna Athingo et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2020)
Healthcare demand in response to rabies elimination campaigns in Latin America
Jonathan Yoder et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Overview of rabies post-exposure prophylaxis access, procurement and distribution in selected countries in Asia and Africa, 2017-2018
N. Sreenivasan et al.
VACCINE (2019)
An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route
Martine Denis et al.
VACCINE (2019)
Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study
Nithya J. Gogtay et al.
CLINICAL INFECTIOUS DISEASES (2018)
Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus
Pan Kyeom Kim et al.
PLOS ONE (2017)
The Road to Dog Rabies Control and Elimination - What Keeps Us from Moving Faster?
Anna S. Fahrion et al.
FRONTIERS IN PUBLIC HEALTH (2017)
Local infiltration of rabies immunoglobulins without systemic intramuscular administration: An alternative cost effective approach for passive immunization against rabies
Omesh Kumar Bharti et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Perspectives in Diagnosis and Treatment of Rabies Viral Encephalitis: Insights from Pathogenesis
Anita Mahadevan et al.
NEUROTHERAPEUTICS (2016)
A novel rabies vaccine based-on toll-like receptor 3 (TLR3) agonist PIKA adjuvant exhibiting excellent safety and efficacy in animal studies
Yi Zhang et al.
VIROLOGY (2016)
Receptor-mediated increase in rabies virus axonal transport
Shani Gluska et al.
NEURAL REGENERATION RESEARCH (2015)
A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus
Ying Wu et al.
NATURE COMMUNICATIONS (2015)
Everything You Always Wanted to Know About Rabies Virus (But Were Afraid to Ask)
Benjamin M. Davis et al.
ANNUAL REVIEW OF VIROLOGY, VOL 2 (2015)
An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein
Aerin Yoon et al.
PLOS ONE (2015)
Recent Observations on Australian Bat Lyssavirus Tropism and Viral Entry
Dawn L. Weir et al.
VIRUSES-BASEL (2014)
Rabies Post-Exposure Prophylaxis of Overseas Travelers in the International Travel Clinic of the National Medical Center from 2006 to 2012, Korea
Jong Hyun Park et al.
INFECTION AND CHEMOTHERAPY (2014)
Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies Results of in vitro and in vivo studies
Shampur Narayan Madhusudana et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults
Nithya Gogtay et al.
VACCINE (2012)
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
Thomas Tiller et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G
Stephane Roche et al.
SCIENCE (2007)
Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: Fine mapping and escape mutant analysis
WE Marissen et al.
JOURNAL OF VIROLOGY (2005)
Rabies deaths in Pakistan: results of ineffective post-exposure treatment
S Parviz et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2004)
The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure
JM Champion et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2000)
Share Paper
